BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3775002)

  • 21. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The complications of radiotherapy for breast cancer and the treatment for radiation ulcer].
    Li YY; Liang M; Wang JL; Jiao LR; Huang J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2004 Jan; 20(1):13-5. PubMed ID: 15131854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A federal audit of the Belgian radiotherapy departments in breast cancer treatment.
    Van Houtte P; Bourgois N; Renard F; Huget P; D'hoore W; Scalliet P;
    Radiother Oncol; 2007 May; 83(2):178-86. PubMed ID: 17470379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of radiation on cardiac function: electrocardiographic study of breast cancer following radiotherapy].
    Matsubara N; Horiuchi J; Okuyama T; Adachi T; Taniguchi K
    Rinsho Hoshasen; 1973 May; 18(5):315-20. PubMed ID: 4737874
    [No Abstract]   [Full Text] [Related]  

  • 25. Radiation therapy in the management of breast cancer.
    Peters MV
    Proc Natl Cancer Conf; 1970; 6():163-74. PubMed ID: 5458090
    [No Abstract]   [Full Text] [Related]  

  • 26. [Costal fractures following radiotherapy of breast cancer].
    Peracchia G; Gagnoni Schippisi G; Bocchi R
    Radiobiol Radioter Fis Med; 1965; 20(5):327-80. PubMed ID: 5855377
    [No Abstract]   [Full Text] [Related]  

  • 27. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
    Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM
    Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design.
    Prochazka M; Hall P; Gagliardi G; Granath F; Nilsson BN; Shields PG; Tennis M; Czene K
    J Clin Oncol; 2005 Oct; 23(30):7467-74. PubMed ID: 16234513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is adjuvant hypofractionated radiotherapy appropriate for elderly patients with breast cancer?
    Recht A
    Nat Clin Pract Oncol; 2005 May; 2(5):244-5. PubMed ID: 16264959
    [No Abstract]   [Full Text] [Related]  

  • 30. [Modification of the radiation reaction using Tanderil].
    Mühleisen H; Vörtler HH
    Strahlentherapie; 1970 Jun; 139(6):707-12. PubMed ID: 4934260
    [No Abstract]   [Full Text] [Related]  

  • 31. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer.
    Hooning MJ; Aleman BM; Hauptmann M; Baaijens MH; Klijn JG; Noyon R; Stovall M; van Leeuwen FE
    J Clin Oncol; 2008 Dec; 26(34):5561-8. PubMed ID: 18854572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
    Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
    Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer.
    Korreman SS; Pedersen AN; Aarup LR; Nøttrup TJ; Specht L; Nyström H
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1375-80. PubMed ID: 16750314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer.
    Wolfort R; de Benedetti A; Nuthalapaty S; Yu H; Chu QD; Li BD
    Surgery; 2006 Aug; 140(2):161-9. PubMed ID: 16904965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lesions of bone tissue following breast carcinoma treated radiotherapeutically].
    Guzecki A
    Pol Przegl Radiol Med Nukl; 1973; 37(2):277-81. PubMed ID: 4701599
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunological tests in assessing different doses for preoperative radiation therapy of breast cancer].
    Iakimova TP; Gerinshteĭn IG; Pashchenko NS
    Med Radiol (Mosk); 1981 Sep; 26(9):36-41. PubMed ID: 7300615
    [No Abstract]   [Full Text] [Related]  

  • 37. [Increasing the radioresistance of normal tissue using hypoxia in the radiotherapy of breast cancer].
    Cyb AF; Mardynsky JuS ; Strelcov RB
    Radiobiol Radiother (Berl); 1986; 27(4):447-50. PubMed ID: 3775002
    [No Abstract]   [Full Text] [Related]  

  • 38. High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.
    Koukourakis MI; Yannakakis D
    Anticancer Res; 2001; 21(4B):2973-8. PubMed ID: 11712796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The immediate and late results of protecting the patient's normal tissues by using the gas hypoxic mixture GHM-10 in the radiation therapy of breast cancer].
    Strelkov RB; Mardynskiĭ IuS; Zakoshchikov KF; Firsova PP
    Vopr Onkol; 1985; 31(12):35-9. PubMed ID: 4082505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?
    Röper B; Kaisig D; Auer F; Mergen E; Molls M
    Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.